0.9001 USD
+0.05 (+5.89%)
0.9 USD
0 (-0.01%)
Overall ONMD gets a fundamental rating of 0 out of 10. We evaluated ONMD against 35 industry peers in the Health Care Technology industry. ONMD has a bad profitability rating. Also its financial health evaluation is rather negative. ONMD does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year ONMD has reported negative net income.
- In the past year ONMD has reported a negative cash flow from operations.
- In the past 5 years ONMD always reported negative net income.
- In the past 5 years ONMD reported 4 times negative operating cash flow.
1.2 Ratios
- ONMD has a Return On Assets of -150.07%. This is amonst the worse of the industry: ONMD underperforms 91.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -150.07% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-1920.19%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ONMD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- ONMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for ONMD has been increased compared to 1 year ago.
- Compared to 1 year ago, ONMD has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -111.97, we must say that ONMD is in the distress zone and has some risk of bankruptcy.
- ONMD has a Altman-Z score of -111.97. This is amonst the worse of the industry: ONMD underperforms 97.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -111.97 |
ROIC/WACCN/A
WACC8.63%
2.3 Liquidity
- ONMD has a Current Ratio of 0.29. This is a bad value and indicates that ONMD is not financially healthy enough and could expect problems in meeting its short term obligations.
- ONMD's Current ratio of 0.29 is on the low side compared to the rest of the industry. ONMD is outperformed by 91.43% of its industry peers.
- A Quick Ratio of 0.29 indicates that ONMD may have some problems paying its short term obligations.
- ONMD's Quick ratio of 0.29 is on the low side compared to the rest of the industry. ONMD is outperformed by 91.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.29 | ||
| Quick Ratio | 0.29 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 93.45% over the past year.
- ONMD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -69.79%.
- The Revenue for ONMD have been decreasing by -16.18% on average. This is quite bad
EPS 1Y (TTM)93.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.89%
Revenue 1Y (TTM)-69.79%
Revenue growth 3Y-16.18%
Revenue growth 5YN/A
Sales Q2Q%24.65%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ONMD. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- ONMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
0.9001
+0.05 (+5.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners23.51%
Inst Owner Change0%
Ins Owners58.25%
Ins Owner Change7.18%
Market Cap45.91M
Revenue(TTM)495.00K
Net Income(TTM)-2.26M
AnalystsN/A
Price TargetN/A
Short Float %2.9%
Short Ratio0.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 92.76 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.01
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -150.07% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-1920.19%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 3101.22% | ||
| Cap/Sales | 513.74% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.29 | ||
| Quick Ratio | 0.29 | ||
| Altman-Z | -111.97 |
F-Score3
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)1855.97%
Cap/Depr(5y)N/A
Cap/Sales(3y)156.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-69.79%
Revenue growth 3Y-16.18%
Revenue growth 5YN/A
Sales Q2Q%24.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-112.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.18%
OCF growth 3YN/A
OCF growth 5YN/A
ONEMEDNET CORP / ONMD FAQ
What is the ChartMill fundamental rating of ONEMEDNET CORP (ONMD) stock?
ChartMill assigns a fundamental rating of 0 / 10 to ONMD.
What is the valuation status of ONEMEDNET CORP (ONMD) stock?
ChartMill assigns a valuation rating of 0 / 10 to ONEMEDNET CORP (ONMD). This can be considered as Overvalued.
What is the profitability of ONMD stock?
ONEMEDNET CORP (ONMD) has a profitability rating of 0 / 10.